Holen Sie sich die Stockscreener-App
0.5602
20.37%
0.0948
Handel nachbörslich:
.56
-0.0002
-0.04%
Schlusskurs vom Vortag:
$0.4654
Offen:
$0.4654
24-Stunden-Volumen:
4.34M
Relative Volume:
3.04
Marktkapitalisierung:
$80.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.415
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
+25.83%
1M Leistung:
+8.88%
6M Leistung:
+1.98%
1J Leistung:
-93.32%
1-Tages-Spanne:
$0.4526
$0.58
1-Wochen-Bereich:
$0.43
$0.58
52-Wochen-Spanne:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Vergleichen Sie APLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.5602 | 67.02M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Applied Therapeutics ($APLT) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView
Detecting price anomalies in Applied Therapeutics Inc. with AIMarket Growth Report & Breakout Confirmation Trade Signals - newser.com
When is the best time to exit Applied Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - newser.com
Is Applied Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Why Applied Therapeutics Inc. is moving today2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Will Applied Therapeutics Inc. continue its uptrendTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Applied Therapeutics Agrees to Pay Settlement to $APLT Investors — Here’s How to Get Your Share - TradingView
Automated trading signals detected on Applied Therapeutics Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Will Applied Therapeutics Inc. see short term momentumEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
2025-09-21 | Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | NDAQ:APLT | Press Release - Stockhouse
Analysts Set Applied Therapeutics Inc. (NASDAQ:APLT) Target Price at $6.10 - MarketBeat
What MACD and RSI say about Applied Therapeutics Inc.Insider Selling & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Applied Therapeutics Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Custom strategy builders for tracking Applied Therapeutics Inc.Risk Management & Stepwise Trade Signal Implementation - newser.com
What to expect from Applied Therapeutics Inc. in the next 30 daysJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Predicting Applied Therapeutics Inc. trend using moving averages2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
How to recover losses in Applied Therapeutics Inc. stockRate Hike & Low Drawdown Investment Strategies - newser.com
What moving averages say about Applied Therapeutics Inc.July 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Signal strength of Applied Therapeutics Inc. stock in tech scannersMarket Activity Report & Technical Pattern Based Signals - newser.com
Evaluating Applied Therapeutics Inc. with trendline analysis2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Advanced analytics toolkit walkthrough for Applied Therapeutics Inc.2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Applied Therapeutics Inc backed by strong institutional buyingWeekly Trade Report & Weekly Momentum Picks - khodrobank.com
Applied Therapeutics Inc. (NASDAQ:APLT) Receives $6.10 Average Target Price from Analysts - Defense World
Quarterly Recap: Can Applied Therapeutics Inc keep up with sector leadersPortfolio Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Applied Therapeutics Announces New Equity Offering Agreement - MSN
How moving averages guide Applied Therapeutics Inc. tradingMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
Wall Street Recap: Can Applied Therapeutics Inc continue delivering strong returnsJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - ACCESS Newswire
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
Smart Money: Can Applied Therapeutics Inc continue delivering strong returnsWall Street Watch & Pattern Based Trade Signal System - خودرو بانک
Can Applied Therapeutics Inc maintain sales growthMarket Growth Summary & Daily Stock Trend Reports - خودرو بانک
Market Trends: Can Applied Therapeutics Inc continue delivering strong returns2025 Growth vs Value & Daily Market Momentum Tracking - خودرو بانک
Quarterly Risk: What is Applied Therapeutics Incs valuation compared to sectorQuarterly Performance Summary & Real-Time Chart Pattern Alerts - خودرو بانک
Trading Recap: Is Applied Therapeutics Inc. in a bullish channelTrade Entry Summary & Fast Momentum Entry Tips - خودرو بانک
Portfolio Shifts: Is RNGR stock technically oversoldJuly 2025 Market Mood & Daily Entry Point Alerts - khodrobank.com
Update Report: Does Applied Therapeutics Inc. have strong fundamentals2025 Market Overview & AI Driven Price Predictions - خودرو بانک
Fed Watch: Will Applied Therapeutics Inc. benefit from sector rotationDay Trade & Safe Capital Growth Plans - خودرو بانک
Silicon Valley - FinancialContent
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Applied Therapeutics Inc. stock trend forecast2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):